Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Dec 30;19(12):pyw080.
doi: 10.1093/ijnp/pyw080. Print 2016 Dec.

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model

Affiliations
Comparative Study

Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model

Bangkun Yang et al. Int J Neuropsychopharmacol. .

Abstract

Background: Current data on antidepressant action of the N-methyl-D-aspartate receptor antagonist, (+)-MK-801, is inconsistent. This study was conducted to examine the effects of (+)-MK-801 and its less potent stereoisomer, (-)-MK-801, in the social defeat stress model of depression.

Methods: The antidepressant effects of (+)-MK-801 (0.1mg/kg) and (-)-MK-801 (0.1mg/kg) in the social defeat stress model were examined.

Results: In the tail suspension and forced swimming tests, both stereoisomers significantly attenuated increased immobility time in susceptible mice. In the sucrose preference test, (+)-MK-801, but not (-)-MK-801, significantly enhanced reduced sucrose consumption 2 or 4 days after a single dose. However, no antianhedonia effects were detected 7 days after a single dose of either stereoisomer.

Conclusions: Both stereoisomers of MK-801 induced rapid antidepressant effects in the social defeat stress model, although neither produced a long-lasting effect (7 days).

Keywords: MK-801; NMDA receptor; antidepressant; ketamine; stereoisomer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The schedule of social defeat stress, drug administration, and behavioral tests. Repeated social defeat stress was performed for 10 days (day 1 to day 10). Social interaction test was performed day 11, and susceptible mice were used in the subsequent experiments. Vehicle, (+)-MK-801 (0.1mg/kg), or (-)-MK-801 (0.1mg/kg) was administered i.p. (day 12). Locomotion test (LMT) and tail suspension test (TST) were performed 4 and 6 hours after a single injection, respectively (day 12). Forced swimming test (FST) was performed 1 day after injection (day 13). A 1% sucrose preference test (SPT) was performed 2 days (day 14), 4 days (day 15), and 7 days (day 19) after a single injection.
Figure 2.
Figure 2.
Antidepressant effects of (+)-MK-801 and (-)-MK-801 in social defeat stress model. Behavioral tests were performed as described in the Figure 1. A: LMT (day 12), B: TST (day 12), C: FST (day 13), D: SPT (day 14) E: SPT (day 16) and F: SPT (day 19). The values represent the mean ± SEM (n = 9 or 10). *P < .05, ** P < .01, *** P < .001 compared with the vehicle-treated stress group. Con: control; Veh: vehicle; (+)MK: (+)-MK-801; (-)MK: (-)-MK-801; LMT: locomotion test; TST: tail suspension test; FST: forced swimming test; SPT: 1% sucrose preference test.

Similar articles

Cited by

References

    1. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM. (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91–95. - PMC - PubMed
    1. Domino EF. (2010) Taming the ketamine tiger. 1965. Anesthesiology 113:678–684. - PubMed
    1. Gerhard DM, Wohleb ES, Duman RS. (2016) Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity. Drug Discov. Today 21:454–464. - PMC - PubMed
    1. Haj-Mirzaian A, Kordjazy N, Haj-Mirzaian A, Ostadhadi S, Ghasemi M, Amiri S, Faizi M, Dehpour A. (2015) Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests. Psychopharmacology (Berl) 232:3551–3561. - PubMed
    1. Hashimoto K. (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105–123. - PubMed

Publication types

MeSH terms